Corcept Therapeutics Incorporated (NASDAQ: CORT) is one of the growth stocks that could double by 2027. On July 14, CORT ...

Her doctor prescribed an antidepressant, even though the then 36-year-old insisted she wasn’t depressed. She even went to ...

This week on "The Readout LOUD" podcast, a mother whose son has Duchenne muscular dystrophy shares her perspective on Sarepta ...

Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...

A Food and Drug Administration expert panel has reignited a debate over whether hormone therapy should be used to treat ...

AstraZeneca said on Thursday its experimental therapy, gefurulimab, met the primary goal and all secondary endpoints in a ...

To suggest Sarepta Therapeutics may not survive its gene therapy crisis is a sobering claim to make, STAT's Adam Feuerstein ...

The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus ...

The small pilot trial found fecal microbiota transplantation was safe in long-term acute care hospital patients colonized ...

Ketamine or "K" is known as a party drug. Lately, it is being used to treat depression and mood disorders. For Brut, filmmaker Léo Hamelin visited a wellness center in New York during a psychedelic ...

Researchers at the National University of Singapore (NUS) have found new applications of magnetic field therapy with ...

The Swiss company, which markets Elevidys abroad, said it believes the benefit-risk balance to treatment remains positive in ...